Background It remains uncertain whether continuous positive airway pressure (CPAP)
therapy would significantly impact hard clinical outcomes in patients with obstructive sleep …

Purpose Continuous positive airway pressure (CPAP) therapy may decrease the risk of
mortality and cardiovascular events in patients with obstructive sleep apnea. However, these …

Obstructive sleep apnea (OSA) commonly occurs in patients with increased cardiovascular
(CV) risk, and continuous positive airway pressure (CPAP) is the preferred therapy for these …

Purpose The associations between obstructive sleep apnea (OSA) and all-cause and
cardiovascular mortality are well established but are not entirely consistent. To accurately …

Aims To assess whether continuous positive airway pressure (CPAP) therapy reduces major
adverse cardiovascular events (MACE) in patients with moderate-to-severe obstructive …

Obstructive sleep apnea (OSA) is associated with increased cardiovascular morbidity and
mortality. Continuous positive airway pressure (CPAP) is the main treatment of OSA. The …

Abstract Study Objectives Randomized controlled trials (RCTs) have shown no reduction in
adverse cardiovascular (CV) events in patients randomized to continuous positive airway …

Context Continuous positive airway pressure (CPAP) is the first-line treatment for patients
with symptomatic obstructive sleep apnea (OSA). However, its indication for all patients with …

Obstructive sleep apnea (OSA) is associated with the progression of cardiovascular disease
(CVD), particularly in the middle-aged population. However, the clinical importance of OSA …

Background Obstructive sleep apnea (OSA) is highly prevalent in patients with coronary
artery disease (CAD) and is associated with recurrent cardiovascular risk. However, whether …